Stock market
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
Completed IND-enabling in vitro Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) studies, demonstrating favorable and efficient oral absorption and systemic bioavailability Results further derisk the potential for drug-drug interactions, provide additional data supporting the safety profile of EB-003 CAMBRIDGE, Mass. — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic […]
Read the full story at Financial PostOpen in the live monitor